Timothy Madden

Phase I Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Solid Tumors With Observations in Androgen-Independent Prostate Cancer

Christos N. Papandreou, Danai Daliani, Darrell Nix et al. · Journal of Clinical Oncology · 2004 · 437 citations · Full text

Medicine, Oncology, Pharmacology +12

Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS

Marcos de Lima, Daniel R. Couriel, Peter F. Thall et al. · Blood · 2004 · 422 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo

Arifumi Iwamaru, Sławomir Szymański, Eiji Iwado et al. · Oncogene · 2006 · 369 citations

Life Sciences, Oncology, Pharmacology +11

A Novel Small Molecule Inhibitor of Signal Transducers and Activators of Transcription 3 Reverses Immune Tolerance in Malignant Glioma Patients

S. Farzana Hussain, Ling-Yuan Kong, Justin Jordan et al. · Cancer Research · 2007 · 311 citations

Life Sciences, Immunology, Oncology +17

Phase I Study of Recombinant Human Endostatin in Patients With Advanced Solid Tumors

Roy S. Herbst, Kenneth R. Hess, Hai T. Tran et al. · Journal of Clinical Oncology · 2002 · 277 citations

Medicine, Pharmacokinetics, Pharmacology +14